Effect of pizotifen on convulsive effect of meso-tetra-4N-methyl-pirydyl-porphyrin [P] in mice

• Autorzy: Maksym B. , Habdas J. , Plech A.
• Języki publikacji: EN

Abstrakty

EN

In this report we present effect of pizotifen, an antagonist of serotonin (5-hydroxytryptamine; 5-HT) receptors, on P-induced convulsions in mice. Experiments were conducted on male mice Balby. Convulsive effect P was determined using the following measures: percentage of mice with seizures, the number of seizure episodes/2 h, the latency time of the beginning P-induced seizure activity in mice and P-induced seizure activity of mice determined by score of Racine. Pretreatment mice with pizotifen (0.5 mg/kg ip) did not prevent convulsive effect P, applied ip at the dose of 50 μmol/kg ip (59.3 mg/kg) but significantly shortened the latency time of the beginning of P-induced seizure activity of mice. We conclude that central serotonin receptors are involved in the mechanism of P-induced convulsions.

Słowa kluczowe

EN

meso-tetra-4N-methylpirydyl-porphyrin; convulsive effect; pizotifen effect; mouse; mice

• Wydawca: -
• Czasopismo: Pestycydy
• Rocznik: 2008
• Numer: 1-2
• Opis fizyczny: p.43-49,fig.,ref.

Twórcy

autor

Maksym B.

• Medical University of Silesia, 38 Jordana St., 41-808 Zabrze, Poland

autor

Habdas J.

autor

Plech A.

Bibliografia

• [1] Gutierez P.P., Kunitz O., Wolff C., Frank J., Skin. Pharmacol. Appl. Skin Physiol., 2001, 14, 393-400.
• [2] Kokot F., Choroby wewnętrzne, PZWL, Warszawa 1996, 781-786.
• [3] Kauppinen R., Timonen K., Mustajoki P., Annals of Med., 1994, 26, 31-38.
• [4] Nordmann Y., Puy H., Deybach J.C., J. Hepatol., 1999, 30, 12-16.
• [5] Dougherty T.J., Photochem. Photobiol., 1993, 58, 895-900.
• [6] His R.A., Rosenthal D.I., Gladstein E., Drugs, 1999, 57, (7), 25-734.
• [7] Lewis T.A., Morra M.J., Habdas J., Czuchajowski L., Brown P.D., J. Environm. Quality, 1995, 24, 56-62.
• [8] Plech A., Habdas J., Pol. J. Pharmacol., 2001, 53(Suppl.), 187.
• [9] Plech A., Habdas J., Maksym B., Jakrzewska H., Chemistry and Biochemistry in the Agricultural Production, Enviromental Protection, Human and Animal Heath. (Górecki H., Dobrzański Z., Kafarski P., Eds.) Czech-Pol-Trade, Prague, Brussels 2006, 240-245.
• [10] Plech A., Habdas J., Jakrzewska H., Rykaczewska-Czerwińska M., Maksym B., Madejska I., Chemistry and Biochemistry in the Agricultural Production, Enviromental Protection, Human and Animal Heath, (Górecki H., Dobrzański Z., Kafarski P. Eds.) Czech-Pol-Trade, Prague, Brussels 2006, 246-250.
• [11] Plech A., Maksym B., Habdas J., Pestycydy/Pesticides, 2004, (3-4), 113-116.
• [12] Noske D.P., Kamphorst W., Wolbers J.G., Sterenborg H.J.C.M., Photochem. Photobiol., 1995, 61, 494-498.
• [13. Maksym B., Habdas J., Plech A., Pestycydy/Pesticides, 2005, (4), 55-63.
• [14] Racine R.J., Electroencephalogr. Clin. Neurophysiol., 1972, 32, 281-294.
• [15] Tallarida R.J., Murray R.B.: Manual of pharmacologic calculations with computer programs II ed., Springer Verlag, N.York 1987, pp. 110-121, 145-148.
• [16] Dixon A.K., Hill R.C., Roemer D., Scholtysik G., Arzneimittel.-Forsch., 1977, 27, 1968-1979.
• [17] Przegaliński E., Baran L., Palider W., Siwanowicz J., Psychopharmacology, 1979, 62, 295-300.
• [18] Plech A., Maksym B., Habdas J., VI Polskie Sympozjum Proekologiczne Pestycydy, Suche k/Poronina, 21-25 czerwiec 2004, Abstract P11.
• [19] Dragunov M., Neurosci. Biobehav. Rev., 1986, 10, 229-244.
• [20] Bagdy G., Kecskemeti V., Riba P., Jakus R., J. Neurochem., 2007, 100, 857-873.
• [21] Pericic D., Svob-Strac D., Brain Res., 2007, 1141, 48-55.
• [22] Lopez-Meraz M.L., Gonzales-Trujano M.E., Nen-Bazan L., Hong E., Rocha L.L., Neuropharmacology, 2005, 49, 367-375.
• [23] Stean T.O., Atkins A.R., Heidbreder C.A., Quinn L.P., Trail B.K., Upton N., Br. J. Pharmacol., 2005, 144, 628-635.